Sarepta Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 655 | 0.0% | 30,454 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 530 | 0.0% | 27,500 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 444 | 0.0% | 25,941 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 1,513 | 0.0% | 23,712 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 2,595 | 0.0% | 21,344 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 2,354 | 0.0% | 18,852 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 2,891 | 0.0% | 18,295 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 2,281 | 0.0% | 17,621 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 1,676 | 0.0% | 17,376 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 1,921 | 0.0% | 15,847 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 1,544 | 0.0% | 13,483 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 1,702 | 0.0% | 12,352 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 1,554 | 0.0% | 11,996 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 1,224 | 0.0% | 11,069 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 807 | 0.0% | 10,764 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 902 | 0.0% | 11,548 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 883 | 0.0% | 9,806 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 674 | 0.0% | 7,292 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 567 | 0.0% | 7,292 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 2,046 | 0.0% | 27,451 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 4,367 | 0.0% | 25,613 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 1,895 | 0.0% | 13,495 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 1,556 | 0.0% | 9,702 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 1,362 | 0.0% | 13,924 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 1,678 | 0.0% | 13,007 | 12/31/2019 |